CGC Canopy Growth Corporation

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Date	Price Target	Rating	Analyst
4/4/2023		Underperform → Mkt Perform	Bernstein
11/2/2022	$1.50	Underperform	Bernstein
10/26/2022		Sell → Hold	Canaccord Genuity
6/8/2022		Market Perform → Underperform	BMO Capital Markets
3/22/2022		Equal Weight → Underweight	Barclays
3/1/2022	$14.00 → $9.00	Equal-Weight	Barclays
2/18/2022	$9.60 → $11.00	Neutral	Cantor Fitzgerald
12/22/2021		Neutral → Underperform	BofA Securities
12/22/2021	$19.00 → $10.00	Neutral → Underperform	B of A Securities
12/20/2021	$11.00 → $7.00	Neutral → Underweight	Piper Sandler

Canopy Growth Corporation

Recent Analyst Ratings for Canopy Growth Corporation

Canopy Growth Corporation Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Financial Officer Hong Judy Eun Joo was granted 7,049 shares and sold $62,866 worth of shares (38,678 units at $1.63), decreasing direct ownership by 5% to 579,889 units (SEC Form 4)

Officer Gedeon Christelle was granted 5,042 shares and sold $14,046 worth of shares (9,555 units at $1.47), decreasing direct ownership by 1% to 389,945 units (SEC Form 4)

Chief Executive Officer Mongeau Luc was granted 727,212 shares, increasing direct ownership by 1,261% to 784,899 units (SEC Form 4)

Chief Financial Officer Hong Judy Eun Joo was granted 424,481 shares, increasing direct ownership by 227% to 611,518 units (SEC Form 4)

Officer Gedeon Christelle was granted 266,023 shares, increasing direct ownership by 207% to 394,458 units (SEC Form 4)

Director Yanofsky Theresa was granted 74,586 shares, increasing direct ownership by 369% to 94,785 units (SEC Form 4)

Director Lazzarato David Angelo was granted 111,879 shares, increasing direct ownership by 489% to 134,765 units (SEC Form 4)

Director Kruh Willy was granted 74,586 shares, increasing direct ownership by 804% to 83,858 units (SEC Form 4)

Director Yanofsky Theresa sold $1,844 worth of shares (2,004 units at $0.92), decreasing direct ownership by 9% to 20,199 units (SEC Form 4)

Director Lazzarato David Angelo sold $2,764 worth of shares (3,004 units at $0.92), decreasing direct ownership by 12% to 22,886 units (SEC Form 4)